Key facts
- Jonathan Milner is an investor with 27 tracked portfolio companies.
- Notable positions include bit.bio, Healx, Nuclera, Axol Bioscience, Relation.
Free account
See the whole book
- ·The book's top 25 — of 27 recorded positions
- ·Watchlist + alerts for Jonathan Milner's activity
Create free account
No card required
Portfolio, priced
27 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| bit.bio | Biotechnology | $546.3M | — | |
| Healx | — | $275.9M | — | |
| Nuclera | — | $154.5M | — | |
| Axol Bioscience | — | $128.1M | — | |
| Relation | — | $124.7M | — | |
| SolasCure | — | $57.0M | — | |
| Invizius | — | $47.8M | — | |
| Quibim | — | $46.1M | — | |
| Pangaea (Enterprise Systems) | — | $37.4M | — | |
| Shift Bioscience | — | $30.5M | — | |
| Enhanced Genomics | — | $28.1M | — | |
| NanoSyrinx | — | $27.4M | — | |
| Equisera | — | $26.5M | — | |
| Qkine | — | $15.7M | — | |
| NK:IO | — | $9.2M | — | |
| + 12 more companies · a free account shows the top of the book | ||||
Frequently asked
- What companies does Jonathan Milner invest in?
- Jonathan Milner has 27 recorded portfolio companies, including bit.bio, Healx, Nuclera, Axol Bioscience.